BFG-33284-48913
3 vaccinations
4 coded responses
31 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 040 / ME
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
- 2021-01-02
- 2021-01-09
- 2021-01-19
-
2021-01-25
Dose 2 — Moderna
- 2021-01-25
-
2021-01-25
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-01-26
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Metallic taste in my mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Metallic taste still presentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessFree text: Slight metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness · Fatigue or tirednessAdult check-in
-
2021-02-01
Health check-in — day 7, dose 2Feeling: Fair · Site: Redness · Headache, Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-09
- 2021-07-28
-
2021-10-27
Dose 3 — Pfizer-BioNTech
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-10
- 2021-11-19
- 2021-11-25
- 2021-12-01
- 2021-12-08
- 2022-01-28
-
2022-04-27
Survey response — 6 months, dose 3MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Gestational diabetesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-29
- 2022-10-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-10-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Metallic taste in my mouth
Systemic reaction (other): Metallic taste still present
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Slight metallic taste in mouth
Release 11 — 6 months, dose 3
Symptoms: Gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release